Amicus Therapeutics Inc (NASDAQ:FOLD)
| 15.11 Delayed Data As of 3:59pm ET |  +0.32 / +2.16%Today’s Change | 6.25 Today|||52-Week Range 16.13 | +55.13% Year-to-Date |
Latest FOLD News | Press Releases
No recent news for Amicus Therapeutics Inc.
Today’s Trading
| Previous close | 14.79 |
| Today’s open | 14.94 |
| Day’s range | 14.80 - 15.14 |
| Volume | 44,977 |
| Average volume (3 months) | 3,016,775 |
| Market cap | $3.7B |
Data as of 3:59pm ET, 08/05/2020
Growth & Valuation
| Earnings growth (last year) | +21.08% |
| Earnings growth (this year) | +30.23% |
| Earnings growth (next 5 years) | -100.00% |
| Revenue growth (last year) | +99.72% |
| P/E ratio | NM |
| Price/Sales | 12.85 |
| Price/Book | 7.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHVNBiohaven Pharmaceuti... | -0.12 | -0.18% |
| ALLKAllakos Inc | +1.28 | +1.61% |
| ---- | ||
| CCXIChemoCentryx Inc | +1.03 | +1.90% |
Data as of 3:59pm ET, 08/05/2020
Financials
| Next reporting date | August 10, 2020 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $182.2M |
| Annual profit (last year) | -$356.4M |
| Net profit margin | -195.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |
Forecasts
